top of page

Nottingham Respiratory Research Unit

RAINIER IPF Study

Glenn Hearson
Jan 20, 2016
1 min read

Updated: Feb 21, 2023

Completed IPF Study

Multi-Center Study Commercial Clinical Trial to Assess the Efficacy and Safety of GS-6624 in Subjects with Idiopathic Pulmonary Fibrosis.

Principle Investigator: Professor Gisli Jenkins

Recent Posts

Study Investigating the Safety and Efficacy of Nalbuphine Extended-Release Tablets (NAL ER) for the Treatment of Cough in Idiopathic Pulmonary Fibrosis (IPF)

Study Investigating the Safety and Efficacy of Nalbuphine Extended-Release Tablets (NAL ER) for the Treatment of Cough in Idiopathic Pulmonary Fibrosis (IPF)

DYNamic assessment of multi-organ level dysfunction in patients recovering from COVID-19: DYNAMO COVID-19 findings published

DYNamic assessment of multi-organ level dysfunction in patients recovering from COVID-19: DYNAMO COVID-19 findings published

Excel in Science Undergraduate students win abstract presentations at national meetings for their presentations titled “Will you regret dumping your X? Sex as a biological variable in Asthma Genomics”

Excel in Science Undergraduate students win abstract presentations at national meetings for their presentations titled “Will you regret dumping your X? Sex as a biological variable in Asthma Genomics”

bottom of page